ALFA Finder| Revenue growth | FY26 growth 3% YoY; Q4 grew 2% YoY. |
|---|---|
| Margins | FY26 EBITDA margin 25%; FY27 guided to mid-20s. |
| Order book | Extension of BMS partnership to 2035 provides long-term visibility. |
| Demand visibility | Strong interest in Unit 3 biologics and ADC discovery lab. |
| Management confidence | Confident in long-term momentum despite near-term Librela and leadership transitions. |
Growth
FY26 revenue up 3% YoY; Q4 revenue INR 1,037 Cr (up 2% YoY, 13% QoQ). FY26 PAT before exceptions down 20%.
Outlook
FY27 revenue guidance flat YoY; growth weighted to H2. Targeting strategic reset for stronger growth from FY28 onwards.
Risks
Continued Librela destocking impact through H1 FY27; geopolitical uncertainties; high staff and utility costs from new facilities.
Earnings Call filed with NSE, NSE: SYNGENE. Summary written with AI assistance from the document.
Syngene International Ltd: key numbers
- Share price
- ₹446.10
- Market cap
- ₹18,008 Cr
- Revenue (annual)
- ₹3,739 Cr
- Net profit (annual)
- ₹316.7 Cr
- P/E (TTM)
- 96.8×Sector 43.8×
- Promoter holding
- 52.59%+0.00% QoQ
- FII holding
- 10.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Syngene International Ltd
All →Syngene International Earnings Call Transcript: Key Takeaways
Syngene reports a transitional quarter with sequential recovery but YoY declines due to the absence of the large Librela revenue stream.
Syngene International Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs 833 Cr (down 9% YoY, up 13% QoQ). Operating EBITDA margin 18% on forex hedge losses. PAT before exceptionals Rs 38 Cr (down 44% YoY). Focus on integrated CRDMO and first Bayview biologics deal.
Syngene International Results Update
Syngene reported Q2 FY27 revenue of Rs 833 Crore, up 13% sequentially, with PAT of Rs 32 Crore. Release includes P&L highlights and business updates.
Syngene International Management Change
Syngene reports changes in senior management: two heads move from SMP to Non-SMP, Ajay Tandon resigns effective October 30, 2026, and CFO Deepak Jain plans to leave. The CFO is a KMP, so this is a material leadership change.
Syngene International Q2 FY27 Results: Net Profit ₹32.2 Cr, Down 52.0% YoY
Syngene International Ltd reported revenue from operations of ₹832.7 Cr (-8.6% YoY) and net profit of ₹32.2 Cr (-52.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹32.2 Cr · -52.0% YoY
Syngene International Other Announcement
Syngene International Limited has submitted the quarterly certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the period ended September 30, 2026.